title: Progesterone and Synthetic Progestin Controversies--Reply.
authors.affiliation: Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada.
authors.forename: Purna A
authors.initials: PA
authors.lastname: Joshi
authors.affiliation: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Goodwin
authors.affiliation: Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada.
authors.forename: Rama
authors.initials: R
authors.lastname: Khokha
mesh_terms: D001943:Breast Neoplasms / Q000139:chemically induced*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects*
chemical_list: D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate